S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells.
Combining more than one drug and combining chemotherapy with radiation therapy may kill more
tumor cells.
PURPOSE: Phase II trial to study the effectiveness of chemotherapy plus radiation therapy in
treating patients with advanced cancer of the nasopharynx.
Phase:
Phase 2
Details
Lead Sponsor:
Southwest Oncology Group
Collaborators:
Eastern Cooperative Oncology Group National Cancer Institute (NCI)